These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 34451400)

  • 21. COVID-19 as a trigger of Guillain-Barré syndrome: A review of the molecular mechanism.
    Malekpour M; Khanmohammadi S; Meybodi MJE; Shekouh D; Rahmanian MR; Kardeh S; Azarpira N
    Immun Inflamm Dis; 2023 May; 11(5):e875. PubMed ID: 37249286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Isolated facial diplegia as an atypical variant of Guillain-Barre syndrome after suspected SARS-CoV-2 infection].
    Lavilla Olleros C; López-Rubio M; Fanciulli C; González-Munera A; Millán Núñez-Cortés J
    Rev Fac Cien Med Univ Nac Cordoba; 2021 Dec; 78(4):405-407. PubMed ID: 34962738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Impact of COVID-19 on the Guillain-Barré Syndrome Incidence.
    Kopańko M; Zabłudowska M; Zajkowska M; Gudowska-Sawczuk M; Mucha M; Mroczko B
    Biomedicines; 2024 Jun; 12(6):. PubMed ID: 38927455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19).
    Harapan BN; Yoo HJ
    J Neurol; 2021 Sep; 268(9):3059-3071. PubMed ID: 33486564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Urodynamic AUR in Guillain-Barré syndrome post-infection by coronavirus Sars-CoV-2. A bibliographic review.].
    Méndez-Rubio S; Laso-Martín S; Jerez-Izquierdo T; Lorenzo-García C; López-Pérez E; Vives-Dilme R; Fernández-Hernández L; Méndez-Cea B; Moreno-Sierra J; Virseda-Chamorro M; Salinas-Casado J
    Arch Esp Urol; 2022 Jan; 75(1):7-18. PubMed ID: 35173070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Guillain-Barré Syndrome Following the BNT162b2 mRNA COVID-19 Vaccine.
    Algahtani HA; Shirah BH; Albeladi YK; Albeladi RK
    Acta Neurol Taiwan; 2023 Jun; 32(2)():82-85. PubMed ID: 37198513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Neuromuscular complications of SARS-CoV-2 infections-Part 1: peripheral nerves].
    Lehmann HC; Schoser B; Wunderlich G; Berlit P; Fink GR
    Nervenarzt; 2021 Jun; 92(6):540-547. PubMed ID: 33770191
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurological manifestations of COVID-19: available evidences and a new paradigm.
    Khatoon F; Prasad K; Kumar V
    J Neurovirol; 2020 Oct; 26(5):619-630. PubMed ID: 32839951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between covid-19 vaccination, SARS-CoV-2 infection, and risk of immune mediated neurological events: population based cohort and self-controlled case series analysis.
    Li X; Raventós B; Roel E; Pistillo A; Martinez-Hernandez E; Delmestri A; Reyes C; Strauss V; Prieto-Alhambra D; Burn E; Duarte-Salles T
    BMJ; 2022 Mar; 376():e068373. PubMed ID: 35296468
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Review article on COVID-19 and Guillain-Barré syndrome.
    Patnaik UJ
    Front Biosci (Schol Ed); 2021 Jun; 13(1):97-104. PubMed ID: 34256532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SARS-CoV-2-Associated Guillain-Barre Syndrome Obscured by Diabetes Mellitus Peripheral Neuropathy.
    Brown M; Petrassi A; Bureau BL; Khan N; Jha P
    Cureus; 2021 Mar; 13(3):e14209. PubMed ID: 33948399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurological manifestations of COVID-19 and other coronaviruses: A systematic review.
    Correia AO; Feitosa PWG; Moreira JLS; Nogueira SÁR; Fonseca RB; Nobre MEP
    Neurol Psychiatry Brain Res; 2020 Sep; 37():27-32. PubMed ID: 32834527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. COVID-19 and Guillain-Barré Syndrome: A Case Report and Review of Literature.
    Zito A; Alfonsi E; Franciotta D; Todisco M; Gastaldi M; Cotta Ramusino M; Ceroni M; Costa A
    Front Neurol; 2020; 11():909. PubMed ID: 32973665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Guillain-Barré syndrome after SARS-CoV-2 infection in an international prospective cohort study.
    Luijten LWG; Leonhard SE; van der Eijk AA; Doets AY; Appeltshauser L; Arends S; Attarian S; Benedetti L; Briani C; Casasnovas C; Castellani F; Dardiotis E; Echaniz-Laguna A; Garssen MPJ; Harbo T; Huizinga R; Humm AM; Jellema K; van der Kooi AJ; Kuitwaard K; Kuntzer T; Kusunoki S; Lascano AM; Martinez-Hernandez E; Rinaldi S; Samijn JPA; Scheidegger O; Tsouni P; Vicino A; Visser LH; Walgaard C; Wang Y; Wirtz PW; Ripellino P; Jacobs BC;
    Brain; 2021 Dec; 144(11):3392-3404. PubMed ID: 34553216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Guillain-Barré Syndrome as a Neurological Complication of Novel COVID-19 Infection: A Case Report and Review of the Literature.
    Paybast S; Gorji R; Mavandadi S
    Neurologist; 2020 Jul; 25(4):101-103. PubMed ID: 32618839
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurological manifestations of COVID-19 and other coronavirus infections: A systematic review.
    Montalvan V; Lee J; Bueso T; De Toledo J; Rivas K
    Clin Neurol Neurosurg; 2020 Jul; 194():105921. PubMed ID: 32422545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurological Complications of COVID-19: Underlying Mechanisms and Management.
    Shehata GA; Lord KC; Grudzinski MC; Elsayed M; Abdelnaby R; Elshabrawy HA
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Severe rapidly progressive Guillain-Barré syndrome in the setting of acute COVID-19 disease.
    Abrams RMC; Kim BD; Markantone DM; Reilly K; Paniz-Mondolfi AE; Gitman MR; Choo SY; Tse W; Robinson-Papp J
    J Neurovirol; 2020 Oct; 26(5):797-799. PubMed ID: 32720233
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Post-COVID-19 Guillain-Barré Syndrome: A Case Report With Literature Review.
    Kaeley N; Kabi A; Pillai A; Shankar T; Ameena M S S
    Cureus; 2022 Jan; 14(1):e21246. PubMed ID: 35178309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients.
    Yachou Y; El Idrissi A; Belapasov V; Ait Benali S
    Neurol Sci; 2020 Oct; 41(10):2657-2669. PubMed ID: 32725449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.